News

A recent study in China reported increased risk of asthma after early-life exposure to particulate matter (PM), with smaller PM leading to a greater risk.

In a recent review, about 35% of participants reported experiencing online child sexual abuse.

An advisory panel for the US Food and Drug Administration voted 14-1 to withdraw 17α-hydroxyprogesterone caproate (Makena; Covis Pharma) from the market.

First Candle’s “Let’s Talk Community Chats” program has launched with the goal of increasing safe sleep in infants to combat sudden unexpectant infant death (SUID).

In a recent study, life expectancy was lower for infants in Census tract areas with a low level of opportunity for children.

The American Academy of Pediatrics, American Medical Association, and Children’s Hospital Association wrote a letter to the Attorney General urging the investigation and prosecution of organizations and individuals threatening hospitals providing evidence-based gender-affirming care to pediatric patients.

Less severe cases of homozygous familial hypercholesterolemia often go undiagnosed and untreated, according to data presented at the AAP National Conference & Exhibition in Anaheim, California from October 7-11.

There is no evidence in the value of screening for depression in individuals aged 11 years and younger.

An analysis of data from more than 9900 people with Down syndrome and 38,000 controls provides new insight into the apparent increase in risk of developing diabetes among children and young adults with Down syndrome.

Dr. Hyams, MD, discusses functional constipation in children and how positive results from a phase 3 trial on linaclotide will change treatment.

Hormonal implants are generally thought to be safe for bone, although whether a young adolescent would reach their genetically determined PBM while using a contraceptive implant is not known.

At the 2022 American Academy of Pediatrics National Conference & Exhibition, research was presented on which children are at high risk of severe COVID-19.

In a recent study, adolescents exposed to vaping prevention advertisements were less susceptible to vaping than those exposed to neutral videos discussing vaping.

Moderna has announced that their latest BA.4/BA.5 Omicron-targeting bivalent COVID-19 booster vaccine, mRNA-1273.222, has been granted Emergency Use Authorization by the US Food and Drug Administration.

Eagle Pharmaceuticals and Enalare Therapeutics have announced that their ENA-001 drug for the treatment of Apnea of Prematurity has been granted an Orphan Drug Designation by the US Food and Drug Administration.

In a recent study, trends of e-cigarette use among middle and high schoolers saw an increase in recent years.

In a recent study, pediatric patients with ADHD were less likely to be hospitalized from a mental disorder or need stimulant prescriptions when given general practitioner centered primary care.

At the American Academy of Pediatrics National Conference & Exhibition, Cassandra Padgett, MS, ACE health coach, discussed how telemedicine intervention effectively managed obesity in pediatric patients during the COVID-19 pandemic.

A recent study independently associated maternal obesity with ADHD risk in offspring, with a significant risk observed in joint obesity and excessive weight gain.

At the 2022 AAP National Conference & Exhibition, a professor of pediatrics describes the benefits of COVID-19 vaccines for children, safety considerations, and urges physicians to continue to urge caregivers to get their children vaccinated.

Natasha Sriraman, MD, general academic pediatrician, discusses the American Academy of Pediatrics conference that took place from October 7, 2022, to October 11, 2022.

In a session at the 2022 AAP National Conference & Exhibition, a physician presenter enumerates unique challenges in treating emerging infectious diseases in children and takes a look at the current pediatric COVID-19 therapies—and evidence gaps.

Sema4|GeneDx has announced its partnership in the GUARDIAN study, a collaboration for screening newborns through whole genome sequencing.

At the 2022 AAP National Conference & Exhibition, one session reviews pediatric considerations for dosing, safety, and regulatory approval for medications and vaccines for SARS-CoV-2, and a look at the Pediatric Trials Network.

Devyani Chowdhury, MD, discusses her session on syncope in young children at the 2022 AAP National Conference & Exhibition.

The approval, awarded to Alnylam Pharmaceuticals, is based on the results of the ILLUMINATE-C phase 3 trial.